(2026). [Ga]Ga-HER2 Affibody PET/CT for early prediction of neoadjuvant therapy outcome in HER2-positive breast cancer: A preliminary report. EJNMMI Research.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"[Ga]Ga-HER2 Affibody PET/CT for Early Prediction of Neoadjuvant Therapy Outcome in HER2-positive Breast Cancer: A Preliminary Report."
EJNMMI Research 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"[Ga]Ga-HER2 Affibody PET/CT for Early Prediction of Neoadjuvant Therapy Outcome in HER2-positive Breast Cancer: A Preliminary Report."
EJNMMI Research, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.